Cingulate inc stock

Author: xrli

August undefined, 2024

WebDec 21, 2024 · CING stock forecast Our latest prediction for Cingulate Inc's stock price was made on the Dec. 21, 2024 when the stock price was at 0.94$.. In the short term (2weeks), CING's stock price should underperform the market by -4.13%.During that period the price should oscillate between -12.22% and +7.08%.. In the medium term (3months), CING's … WebCingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset CTx-1301 for ADHD. Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without …

Cingulate Inc. - CING - Stock Price Today - Zacks

WebFeb 24, 2024 · Matthew Brams, MD, Cingulate Inc’s Chief Medical Officer, said: “CTx-1301 is being developed to provide the proven efficacy of stimulants while addressing the key challenges associated with available formulations, including sub-optimal onset and duration along with burdensome medication regimens which often lead to non-compliance, … WebFind the latest Cingulate Inc. (CING) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for CING stock on Yahoo Finance. View daily, weekly or … Find the latest Cingulate Inc. (CING) stock discussion in Yahoo Finance's forum. … Get the latest Cingulate Inc. (CING) stock news and headlines to help you in your … Find out the direct holders, institutional holders and mutual fund holders for … Get the detailed quarterly/annual income statement for Cingulate Inc. (CING). Find … Cingulate Inc. 1901 West 47th Place Kansas City, KS 66205 United States 913 942 … See Cingulate Inc. (CING) Environment, Social and Governance Ratings to help … Find the latest Cingulate Inc. (CING) stock quote, history, news and other vital … ct ortho walk in clinic

CING Cingulate Inc. Stock Price & News - WSJ

WebThe CING stock price is closed at $ 0.908000 with a total market cap valuation of $ 10.27M (44M shares outstanding). The CING is trading on NASDAQ with the sign CING. CING … WebApr 5, 2024 · It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Sector Health Care. Industry Pharmaceuticals. Employees 15. Founded 2012. Website www.cingulate.com. Address 1901 West 47th Place , Kansas City, United States. WebApr 14, 2024 · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. … ct ortho trumbull

Will Cingulate Inc. (NASDAQ: CING) In 2024 Be Worth Your Money?

Cingulate inc stock

CING Institutional Ownership and Shareholders - Cingulate Inc …

WebApr 5, 2024 · It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Sector … WebMar 27, 2024 · Cingulate Inc (CING) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, ... Cingulate Inc lowest stock price …

Did you know?

Webposterior cingulate cortex was strongly and consis-tently activated during the evaluation of threat-related words [Maddock and Buonocore, 1997]. A subsequent meta-analysis of functional imaging studies showed that the caudal part of the posterior cingulate cortex was the cortical region most consistently activated by WebApr 4, 2024 · In addition to the Phase 3 adult dose-optimization study, Cingulate plans to commence its pivotal Phase 3 fixed-dose pediatric and adolescent study in mid-2024. Assuming positive clinical results from the Phase 3 trials, Cingulate plans to submit a New Drug Application (NDA) for CTx-1301 in the first half of 2024 under the Section 505(b)(2 ...

WebCingulate Inc. Wt historical stock charts and prices, analyst ratings, financials, and today’s real-time CINGW stock price. WebDec 8, 2024 · KANSAS CITY, Kan., Dec. 07, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing its …

WebCingulate upsized its IPO at pricing on Dec. 7, 2024, to 4.17 million shares, up from 3.57 million in the prospectus, and warrants to buy 4.17 million shares of common stock – and priced the IPO at $6 – the low end of its $6-to-$8 range. The IPO raised $25.02 million. The stock is expected to trade under the symbol “CING” and the ... WebApr 13, 2024 · A high-level overview of Cingulate Inc. (CING) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Web20 hours ago · Cingulate Inc. (NASDAQ: CING), is a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...

Web20 hours ago · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. … ct ortho specialists sheltonWebApr 11, 2024 · Cingulate Inc. Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD Jan 05 Independent Director recently bought … earth science partnership irelandWeb2 days ago · View Cingulate Inc CING investment & stock information. Get the latest Cingulate Inc CING detailed stock quotes, stock data, Real-Time ECN, charts, stats and … earth science partnership limitedWebMar 1, 2024 · The trading price of Cingulate Inc. (NASDAQ:CING) closed higher on Tuesday, February 28, closing at $1.79, 13.29% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.55 and $1.88. In examining the 52-week price action we see that the stock hit a 52-week high of … earth science partnership westportWebCingulate Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Cingulate Inc. is a clinical-stage biopharmaceutical … ct orthosisWebFounded Date Dec 1, 2012. Founders Craig Gilgallon, Matthew Brams, Raul Silva, Shane J Schaffer. Operating Status Active. Last Funding Type Venture - Series Unknown. Stock Symbol NASDAQ:CING. Company Type For Profit. Contact Email [email protected]. Phone Number +1 (862) 260-9131. Their unique … c to rustWebCingulate Inc. Common Stock (CING) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. ct or ultrasound for appendicitis